Astec LifeSciences Limited has informed the Exchange regarding Outcome of Rights Issue Committee Meeting held on July 02, 2025.

Corporate Actions View source PDF Explain this filing

ASTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹950.20

prior close

₹955.55

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.1% vs market

Pesticides & Agrochemicals peers, median of 24sector+0.5%-0.5% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.5 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-1.2

15m

-1.4

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.1-0.1+0.5-0.5

Next day

-0.5+0.5-1.0+0.9-1.4

-2.1-0.0-2.1-0.0-2.1

-4.0-0.1-3.9-0.8-3.3

-4.5+0.4-4.9-0.2-4.3

-4.9+0.7-5.6-0.3-4.6

-2.6+0.4-2.9-1.3-1.3

15d

-5.1+1.1-6.1+1.7-6.8

-7.3-2.0-5.3+1.8-9.1

-10.2-1.9-8.3-4.7-5.5

-16.3-2.7-13.6-8.4-8.0

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Astec LifeSciences Limited has approved the Letter of Offer for its proposed Rights Issue on July 2, 2025. The company plans to issue up to 28,01,673 equity shares with a face value of ₹10 each at an issue price of ₹890 per share, raising approximately ₹249.35 crore (assuming full subscription). Eligible shareholders can subscribe in the ratio of 1 rights share for every 7 fully paid-up shares held as on the record date of Friday, July 4, 2025. The Letter of Offer will be filed with BSE, NSE, and SEBI, and made available on the company's website.

Likely market impact

Existing shareholders will need to decide whether to subscribe to their entitlement or let it lapse. The rights issue will dilute existing holdings by approximately 14.3% (1/7 ratio), but brings in fresh capital of up to ~₹249 crore if fully subscribed.